Search

Did You Mean:

Search Results

  • Book
    [edited by] G. Michael Felker, Douglas L. Mann.
    Contents:
    Molecular basis of heart failure
    Cellular basis for heart failure
    Cellular basis for myocardial regeneration and repair
    Myocardial basis for heart failure : role of cardiac interstitium
    Molecular signaling mechanisms of the renin-angiotensin system in heart failure
    Adrenergic receptor signaling in heart failure
    Role of innate immunity in heart failure
    Oxidative stress in heart failure
    Natriuretic peptides in heart failure: pathophysiologic and therapeutic implications
    Systolic dysfunction in heart failure
    Alterations in ventricular function : diastolic heart failure
    Alterations in ventricular structure : role of left ventricular remodeling and reverse remodeling in heart failure
    Alterations in the sympathetic and parasympathetic nervous systems in heart failure
    Alterations in the peripheral circulation in heart failure
    Alterations in kidney function associated with heart failure
    Alterations in skeletal muscle in heart failure
    Alterations in cardiac metabolism in heart failure
    Epidemiology of heart failure
    Heart failure as a consequence of ischemic heart disease
    Heart failure as a consequence of dilated cardiomyopathy
    Restrictive and infiltrative cardiomyopathies and arrhythmogenic right ventricular dysplasia/cardiomyopathy
    Cardiac amyloidosis
    Heart failure as a consequence of hypertrophic cardiomyopathy
    Heart failure as a consequence of genetic cardiomyopathy
    Heart failure as a consequence of hypertension
    Heart failure as a consequence of valvular heart disease
    Heart failure as a consequence of congenital heart disease
    Heart failure as a consequence of viral and nonviral myocarditis
    Heart failure in the developing world
    Heart failure and human immunodeficiency virus
    Clinical evaluation of heart failure
    Cardiac imaging in heart failure
    Biomarkers and precision medicine in heart failure
    Hemodynamics in heart failure
    Disease prevention in heart failure
    Acute heart failure
    Contemporary medical therapy for heart failure patients with reduced ejection fraction
    Management of arrhythmias and device therapy in heart failure
    Treatment of heart failure with preserved ejection fraction
    Management of heart failure in special populations : older patients, women, and racial/ethnic minority groups
    Stem cell-based and gene therapies in heart failure
    Neuromodulation in heart failure
    Pulmonary hypertension
    Heart transplantation
    Circulatory assist devices in heart failure
    Cardio-oncology and heart failure
    Disease management and telemedicine in heart failure
    Management of comorbidities in heart failure
    Quality and outcomes in heart failure
    Decision making and palliative care in advanced heart failure
    Digital Access ClinicalKey 2020
  • Article
    Fletcher GH.
    Radiology. 1978 Apr;127(1):3-19.
    In his overview of the history and theoretical developments of radiotherapy, the author stresses the following concepts: (a) sensitivity is not linked to histology but to the volume of cancer; (b) the dose must not necessarily be homogeneous in the target volume but related to varying volumes of cancer; (c) the fact that irradiation may not be the sole treatment in some tumors does not mean that it does not have a place in their management; (d) as a general rule, large tumors should not be treated with irradiation only, if gross cancer can be resected simply; (e) since there is a dose-response curve for control rates and for complications, an optimum dose level must be maintained; and (f) the patient's quality of life is a major concern.
    Digital Access Access Options